Related Experiment Videos
Transcutaneous bilirubinometry II. Dermal bilirubin kinetics during phototherapy
Insights
Phototherapy effectively reduces cutaneous bilirubin in infants. Transcutaneous bilirubinometer (TcB) readings from unexposed skin are more reliable for monitoring treatment effectiveness than those from exposed areas.
Area of Science:
- Neonatal Medicine
- Dermatology
- Medical Physics
Background:
- Neonatal jaundice is common.
- Phototherapy is a standard treatment.
- Accurate monitoring of bilirubin levels is crucial.
Purpose of the Study:
- To evaluate the impact of phototherapy on cutaneous bilirubin.
- To compare the efficacy of blue versus white light phototherapy.
- To assess the utility of transcutaneous bilirubinometry (TcB) in monitoring phototherapy.
Main Methods:
- 14 white infants received phototherapy (blue or white light).
- Transcutaneous bilirubinometer (TcB) measurements were taken from exposed and covered (patched) skin every 15 minutes for 4 hours.
- TcB readings from patched skin served as controls.
Main Results:
- TcB index from patched skin remained stable, indicating no change in bilirubin under the patch.
- TcB index from exposed skin decreased significantly, especially in the first hour.
- Blue light therapy showed a faster initial TcB index decrease compared to white light within the first 2 hours.
- TcB measurements from exposed skin were less reliable for predicting serum bilirubin response than those from unexposed (patched) sites.
Conclusions:
- Phototherapy effectively reduces cutaneous bilirubin levels.
- TcB measurements from unexposed skin sites can reliably monitor phototherapy's effectiveness in reducing bilirubin.
- Blue light may offer a faster initial reduction in bilirubin levels compared to white light.
Abstract:
We examined the effect of phototherapy on cutaneous bilirubin using the transcutaneous bilirubinometer (TcB) in 14 white infants at a mean postnatal age of 30 h. Six infants were treated with blue light, eight with white light. An opaque patch, 2.5 cm in diameter, covered the skin and served as a source for TcB control values. Simultaneous TcB measurements were obtained from exposed and patched areas every 15 min during 4 h of phototherapy. After the start of phototherapy, TcB index obtained from patched skin did not change during the course of treatment. Data from exposed skin showed that the initial rate of TcB index fall during the first hour was significantly faster than the successive values during the next 3 h in both groups studied. During the first 2 h of therapy the TcB index decreased faster among infants treated with blue light. Correlation studies indicate that TcB measurements from exposed skin areas may not be clinically useful in predicting serum bilirubin response to phototherapy but data obtained from unexposed sites may fill this role.